XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues    
Revenues $ 0 $ 1,445
Costs and expenses    
Research and development 12,095 11,415
General and administrative 3,474 3,106
Depreciation 190 184
Total costs and expenses 15,759 14,705
Loss from operations (15,759) (13,260)
Other income, net 115 304
Net loss and comprehensive loss $ (15,644) $ (12,956)
Net loss per share, basic and diluted (in dollars per share) $ (0.10) $ (0.09)
Weighted average shares outstanding, basic and diluted (in shares) 162,715 145,964
Grant revenue    
Revenues    
Revenues $ 0 $ 4
Healios | Contract revenue    
Revenues    
Revenues $ 0 $ 1,441